跳至主要内容
临床试验/NCT02277262
NCT02277262Unknown4 期

PROPHYlactic Implantation of BIOlogic Mesh in Peritonitis (PROPHYBIOM)

A.O. Ospedale Papa Giovanni XXIII2 个研究点 分布在 1 个国家目标入组 90 人开始时间: 2014年10月1日最近更新:
适应症

试验速览

阶段
4 期
发起方
入组人数
90
试验地点
2
主要终点
Incisional hernia rate

研究概览

简要总结

To evaluate the efficacy of the use of swine dermal collagen prosthesis implanted preperitoneally as a prophylactic procedure against incisional hernia in patients operated in urgency/emergency setting in contaminated/infected fields with peritonitis. The aim of the study is to reduce the incidence of incisional hernia from 50% to 20%.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Prevention
盲法
None

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • • Patients aged > 18 years old
  • Clinical and/or laboratory and/or radiological evidence/signs of peritonitis of any origin (peritoneal reactivity, positive Blumberg sign, fever, free air/fluid in abdominal cavity, leucocytosis, increased CRP (C-reactive protein, lactic dehydrogenase (LDH), tachycardia, tachypnea, clinical or radiological evidence/suspect of bowel ischemia)
  • Eventual strong suspect of possible bacterial translocation (reduction of the natural intestinal barrier against bacterial translocation, i.e. bowel ischemia, bowel overdistension, intestinal occlusion, etc.)
  • Surgical indication for midline laparotomy independently from eventual previous laparotomies
  • Informed consent

排除标准

  • • Patients aged < 18 years old
  • Informed consent refusal
  • No Clinical and/or laboratory and/or radiological evidence/signs of peritonitis of any origin.
  • Surgical indication for laparotomies other than midline one
  • Pregnancy

结局指标

主要结局

Incisional hernia rate

时间窗: 24 months

次要结局

  • Mortality(24 months)
  • Length of surgery(Day 0)
  • Morbidity(24 months)
  • Time to drain removal(participants will be followed for the duration of hospital stay, an expected average of 1-2 weeks)
  • Length of stay in hospital(At the discharge, an expected average of 1-2 weeks after the intervention)

研究者

发起方
A.O. Ospedale Papa Giovanni XXIII
申办方类型
Other
责任方
Principal Investigator
主要研究者

Federico Coccolini

General Surgeon

A.O. Ospedale Papa Giovanni XXIII

研究点 (2)

Loading locations...

相似试验

PROPHYlactic Implantation of BIOlogic Mesh in... | 临床试验